title: Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase.
abstract: A small population of plasmacytoid DCs (pDCs) in mouse tumor-draining LNs can express the immunoregulatory enzyme indoleamine 2,3-dioxygenase (IDO). We show that these IDO+ pDCs directly activate resting CD4+CD25+Foxp3+ Tregs for potent suppressor activity. In vivo, Tregs isolated from tumor-draining LNs were constitutively activated and suppressed antigen-specific T cells immediately ex vivo. In vitro, IDO+ pDCs from tumor-draining LNs rapidly activated resting Tregs from non-tumor-bearing hosts without the need for mitogen or exogenous anti-CD3 crosslinking. Treg activation by IDO+ pDCs was MHC restricted, required an intact amino acid-responsive GCN2 pathway in the Tregs, and was prevented by CTLA4 blockade. Tregs activated by IDO markedly upregulated programmed cell death 1 ligand 1 (PD-L1) and PD-L2 expression on target DCs, and the ability of Tregs to suppress target T cell proliferation was abrogated by antibodies against the programmed cell death 1/PD-L (PD-1/PD-L) pathway. In contrast, Tregs activated by anti-CD3 crosslinking did not cause upregulation of PD-Ls, and suppression by these cells was unaffected by blocking the PD-1/PD-L pathway. Tregs isolated from tumor-draining LNs in vivo showed potent PD-1/PD-L-mediated suppression, which was selectively lost when tumors were grown in IDO-deficient hosts. We hypothesize that IDO+ pDCs create a profoundly suppressive microenvironment within tumor-draining LNs via constitutive activation of Tregs.
authors: Department of Pediatrics, School of Medicine, Medical College of Georgia, Augusta, Georgia 30912, USA.
authors: Madhav D
authors: MD
authors: Sharma
authors: Babak
authors: B
authors: Baban
authors: Phillip
authors: P
authors: Chandler
authors: De-Yan
authors: DY
authors: Hou
authors: Nagendra
authors: N
authors: Singh
authors: Hideo
authors: H
authors: Yagita
authors: Miyuki
authors: M
authors: Azuma
authors: Bruce R
authors: BR
authors: Blazar
authors: Andrew L
authors: AL
authors: Mellor
authors: David H
authors: DH
authors: Munn
mesh_terms: D000818:Animals; D018122:B7-1 Antigen / Q000378:metabolism; D060890:B7-H1 Antigen; D002454:Cell Differentiation; D003713:Dendritic Cells / Q000166:cytology / Q000201:enzymology* / Q000276:immunology*; D006649:Histocompatibility Antigens / Q000276:immunology; D006801:Humans; D050503:Indoleamine-Pyrrole 2,3,-Dioxygenase / Q000378:metabolism*; D008024:Ligands; D008198:Lymph Nodes / Q000166:cytology / Q000276:immunology*; D008207:Lymphatic Metastasis; D008213:Lymphocyte Activation / Q000276:immunology; D008562:Membrane Glycoproteins / Q000378:metabolism; D051379:Mice; D009368:Neoplasm Transplantation; D010455:Peptides / Q000378:metabolism; D015398:Signal Transduction; D050378:T-Lymphocytes, Regulatory / Q000166:cytology / Q000276:immunology*
chemical_list: D018122:B7-1 Antigen; D060890:B7-H1 Antigen; C498919:Cd274 protein, mouse; D006649:Histocompatibility Antigens; D050503:Indoleamine-Pyrrole 2,3,-Dioxygenase; D008024:Ligands; D008562:Membrane Glycoproteins; D010455:Peptides
references: J Clin Invest. 2007 May;117(5):1147-54
references: 17476344
references: Science. 2002 Sep 13;297(5588):1867-70
references: 12228717
references: Lab Invest. 2003 Oct;83(10):1457-66
references: 14563947
references: Nat Immunol. 2003 Dec;4(12):1206-12
references: 14578884
references: Gastroenterology. 2003 Dec;125(6):1762-73
references: 14724829
references: Nat Immunol. 2002 Nov;3(11):1097-101
references: 12368911
references: J Immunol. 2002 Nov 15;169(10):5538-45
references: 12421930
references: J Exp Med. 2003 Feb 17;197(4):403-11
references: 12591899
references: Mol Cell. 2003 Mar;11(3):619-33
references: 12667446
references: Nat Med. 2003 May;9(5):562-7
references: 12704383
references: J Immunol. 2003 Aug 15;171(4):1652-5
references: 12902462
references: Eur J Immunol. 2003 Oct;33(10):2773-82
references: 14515261
references: Eur J Immunol. 2004 Feb;34(2):336-44
references: 14768038
references: Eur J Immunol. 2004 Feb;34(2):366-76
references: 14768041
references: J Immunol. 2004 Apr 1;172(7):4100-10
references: 15034022
references: J Immunol. 2004 Jun 1;172(11):6519-23
references: 15153463
references: J Clin Invest. 2004 Jul;114(2):280-90
references: 15254595
references: Cell. 1994 Jan 14;76(1):17-27
references: 8287475
references: Science. 1994 May 13;264(5161):961-5
references: 7513904
references: Nat Med. 1995 Jul;1(7):649-53
references: 7585145
references: Int Immunol. 1996 May;8(5):765-72
references: 8671665
references: Int Immunol. 1996 Mar;8(3):351-8
references: 8671621
references: J Exp Med. 1998 Jul 20;188(2):287-96
references: 9670041
references: J Immunol. 1998 Aug 15;161(4):1868-74
references: 9712055
references: Science. 1998 Aug 21;281(5380):1191-3
references: 9712583
references: J Exp Med. 1999 May 3;189(9):1363-72
references: 10224276
references: Nat Immunol. 2005 Mar;6(3):280-6
references: 15685176
references: Nat Med. 2005 Mar;11(3):312-9
references: 15711557
references: J Exp Med. 2005 Mar 7;201(5):681-6
references: 15753203
references: Blood. 2005 Apr 1;105(7):2862-8
references: 15591121
references: Immunity. 2005 May;22(5):633-42
references: 15894280
references: Int Immunol. 2005 Jul;17(7):909-19
references: 15967784
references: Biochem Soc Trans. 2006 Feb;34(Pt 1):7-11
references: 16246168
references: Curr Opin Immunol. 2005 Dec;17(6):638-42
references: 16209918
references: Curr Opin Immunol. 2006 Apr;18(2):206-13
references: 16464564
references: Nat Rev Immunol. 2006 Apr;6(4):295-307
references: 16557261
references: Trends Immunol. 2006 Apr;27(4):195-201
references: 16500147
references: Proc Natl Acad Sci U S A. 2006 Apr 25;103(17):6659-64
references: 16617117
references: J Immunol. 2006 Jun 1;176(11):6752-61
references: 16709834
references: J Immunol. 2006 Jul 1;177(1):40-4
references: 16785496
references: Immunol Rev. 2006 Oct;213:146-58
references: 16972902
references: Nat Rev Immunol. 2006 Oct;6(10):715-27
references: 16977338
references: FASEB J. 2006 Nov;20(13):2384-6
references: 17015408
references: Eur J Immunol. 2007 Jan;37(1):129-38
references: 17154262
references: Cancer Res. 2007 Jan 15;67(2):792-801
references: 17234791
references: Nat Immunol. 2007 Mar;8(3):239-45
references: 17304234
references: Blood. 2007 Apr 15;109(8):3351-9
references: 17158233
references: J Immunol. 2000 Jan 1;164(1):183-90
references: 10605010
references: J Exp Med. 2000 Apr 3;191(7):1241-6
references: 10748241
references: Immunity. 2002 Feb;16(2):311-23
references: 11869690
references: Nat Med. 2003 Oct;9(10):1269-74
references: 14502282